Release Date: 27/06/16 09:30 Summary: Trading Halt-BRB.AX Price Sensitive: Yes Download Document 291.05KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%